Key terms
About ABIO
ARCA biopharma, Inc. is a clinical-stage biopharmaceutical company, which engages in the development and commercialization of targeted therapies for cardiovascular diseases. The firm focuses on the cardiovascular pathophysiology, molecular genetics, and clinical development. Its product candidate, Gencaro is a pharmacologic beta-blocker and mild vasodilator, which is developed for the treatment of chronic heart failure and other indications. The company was founded by Michael R. Bristow and Christopher David Ozeroff in 1992 and is headquartered in Westminster, CO.
Sector
Industry
Employees
Founded
Website
Key stock statistics
1-day range
52-week range
Market cap
P/E ratio
Next earnings date
Dividend yield
Ex-dividend date
Dividend pay date
Key terms
Ad Feedback
Smart score
Latest ABIO news
Apr 05
10:40am ET
Biotech Alert: Searches spiking for these stocks today
Apr 04
4:43pm ET
Arca Biopharma Announces Executive Leadership Transition
Apr 03
7:42am ET
Arca Biopharma’s Strategic Merger with Oruka Therapeutics
Apr 03
7:33am ET
ARCA Biopharma, Oruka Therapeutics enter merger agreement
Feb 07
4:53am ET
Arca Biopharma Board Reshuffle as Two Directors Depart
No recent news articles are available for ABIO
ABIO Financials
Key terms
Ad Feedback
ABIO Forecasts
analyst rating
- buy
- hold
- sell
1-year stock price forecast
ABIO Competitors
$ Market cap
P/E ratio
$ Price
1d change
52-week range
